Loading…
Underlying
Underlying Price
$8.48
Type
Call
Strike
7.5
Expiration
Nov 6, 2026
DTE
17d
Moneyness
ITM
Intrinsic
$0.98
IBRX 7.5 Call Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 23, 2026 | 3d | $2.47 | -14.83% | 13 | 24 |
| Oct 30, 2026 | 10d | $2.75 | -17.91% | 4 | 94 |
| Nov 6, 2026 | 17d | — | — | 0 | 0 |
| Nov 13, 2026 | 24d | — | — | 0 | 0 |
| Nov 27, 2026 | 38d | $3.08 | +0.00% | 30 | 30 |
| Jan 15, 2027 | 87d | $2.65 | -11.67% | 315 | 21,039 |
| Jan 21, 2028 | 458d | $4.20 | -10.64% | 9,831 | 18,015 |
IBRX Nearby Strikes · Nov 6, 2026
IBRX Profile
immunitybio is a leading registration-stage immuno-oncology and infectious disease company activating both the innate (natural killer cell and macrophage) and adaptive (t cell) immune system. we are developing molecular and product platforms including n-803, aldoxorubicin, and a second-generation adenovirus vector, which are based upon our three key modalities of activating natural killer ('nk') and t cells, tumoricidal macrophages, and memory t cells.